Northcape Wealth Management LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Northcape Wealth Management LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 4,345 shares of the healthcare conglomerate’s stock after purchasing an additional 37 shares during the period. Northcape Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,198,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Atlas Legacy Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $1,090,000. Bank of Jackson Hole Trust acquired a new stake in UnitedHealth Group during the 4th quarter worth $1,371,000. Callahan Advisors LLC increased its stake in UnitedHealth Group by 0.6% in the fourth quarter. Callahan Advisors LLC now owns 43,835 shares of the healthcare conglomerate’s stock valued at $22,174,000 after purchasing an additional 266 shares during the period. Mcdonald Partners LLC boosted its stake in shares of UnitedHealth Group by 4.0% during the fourth quarter. Mcdonald Partners LLC now owns 2,826 shares of the healthcare conglomerate’s stock worth $1,430,000 after buying an additional 109 shares during the period. Finally, Davidson Investment Advisors purchased a new stake in UnitedHealth Group during the 4th quarter valued at approximately $9,539,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 4.2 %

UNH stock opened at $501.52 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company’s 50 day simple moving average is $521.08 and its 200-day simple moving average is $562.03. The firm has a market capitalization of $461.54 billion, a PE ratio of 32.36, a P/E/G ratio of 1.43 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the business earned $5.83 earnings per share. The business’s revenue was up 6.8% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently commented on UNH. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.